Bioactive medications for the delivery of platelet derivatives to skin wounds

Maria Cristina Bonferoni, Silvia Rossi, Giuseppina Sandri, Carla Caramella, Claudia Del Fante, Cesare Perotti, Dalila Miele, Barbara Vigani, Franca Ferrari

Research output: Contribution to journalReview article

Abstract

Chronic wounds are the result of alterations in the complex series of events of physiological wound healing. In particular, the prolonged inflammation results in increased protease activity, in the degradation of extracellular matrix (ECM) and of growth factors (GFs). The relevance of platelet GFs in maintaining and restoring the complex equilibrium of different moments in wound healing is well recognized. Moreover, the observed decrease of their levels in chronic wounds suggested a possible therapeutic role of the external application to the wounds. It has been also pointed out that tissue regeneration can be more efficiently obtained by the synergic use of different GFs. Platelet derivatives such as platelet-rich plasma (PRP) and platelet lysate (PL) are able to release GFs in a balanced pool. Their therapeutic use in regenerative medicine and wound healing has been therefore more and more frequently proposed in clinical trials and in the literature. The development of a suitable formulation able to control the GFs release rate, to protect the GFs, and to assure their prolonged contact with the wound site, is of paramount importance for the therapeutic success. The present review considers some formulation approaches for PRP and PL application to wounds.

Original languageEnglish
Pages (from-to)472-483
Number of pages12
JournalCurrent Drug Delivery
Volume16
Issue number5
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Intercellular Signaling Peptides and Proteins
Blood Platelets
Skin
Wounds and Injuries
Wound Healing
Platelet-Rich Plasma
Regenerative Medicine
Therapeutic Uses
Extracellular Matrix
Regeneration
Peptide Hydrolases
Clinical Trials
Inflammation
Therapeutics

Keywords

  • Drug delivery systems
  • Extracellular matrix (ECM)
  • Platelet lysate
  • Platelet-rich plasma
  • Skin regeneration
  • Wound healing

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Bioactive medications for the delivery of platelet derivatives to skin wounds. / Bonferoni, Maria Cristina; Rossi, Silvia; Sandri, Giuseppina; Caramella, Carla; Fante, Claudia Del; Perotti, Cesare; Miele, Dalila; Vigani, Barbara; Ferrari, Franca.

In: Current Drug Delivery, Vol. 16, No. 5, 01.01.2019, p. 472-483.

Research output: Contribution to journalReview article

Bonferoni, MC, Rossi, S, Sandri, G, Caramella, C, Fante, CD, Perotti, C, Miele, D, Vigani, B & Ferrari, F 2019, 'Bioactive medications for the delivery of platelet derivatives to skin wounds', Current Drug Delivery, vol. 16, no. 5, pp. 472-483. https://doi.org/10.2174/1381612825666190320154406
Bonferoni, Maria Cristina ; Rossi, Silvia ; Sandri, Giuseppina ; Caramella, Carla ; Fante, Claudia Del ; Perotti, Cesare ; Miele, Dalila ; Vigani, Barbara ; Ferrari, Franca. / Bioactive medications for the delivery of platelet derivatives to skin wounds. In: Current Drug Delivery. 2019 ; Vol. 16, No. 5. pp. 472-483.
@article{d466dec018c149f2ab9d7d8630e71f9f,
title = "Bioactive medications for the delivery of platelet derivatives to skin wounds",
abstract = "Chronic wounds are the result of alterations in the complex series of events of physiological wound healing. In particular, the prolonged inflammation results in increased protease activity, in the degradation of extracellular matrix (ECM) and of growth factors (GFs). The relevance of platelet GFs in maintaining and restoring the complex equilibrium of different moments in wound healing is well recognized. Moreover, the observed decrease of their levels in chronic wounds suggested a possible therapeutic role of the external application to the wounds. It has been also pointed out that tissue regeneration can be more efficiently obtained by the synergic use of different GFs. Platelet derivatives such as platelet-rich plasma (PRP) and platelet lysate (PL) are able to release GFs in a balanced pool. Their therapeutic use in regenerative medicine and wound healing has been therefore more and more frequently proposed in clinical trials and in the literature. The development of a suitable formulation able to control the GFs release rate, to protect the GFs, and to assure their prolonged contact with the wound site, is of paramount importance for the therapeutic success. The present review considers some formulation approaches for PRP and PL application to wounds.",
keywords = "Drug delivery systems, Extracellular matrix (ECM), Platelet lysate, Platelet-rich plasma, Skin regeneration, Wound healing",
author = "Bonferoni, {Maria Cristina} and Silvia Rossi and Giuseppina Sandri and Carla Caramella and Fante, {Claudia Del} and Cesare Perotti and Dalila Miele and Barbara Vigani and Franca Ferrari",
year = "2019",
month = "1",
day = "1",
doi = "10.2174/1381612825666190320154406",
language = "English",
volume = "16",
pages = "472--483",
journal = "Current Drug Delivery",
issn = "1567-2018",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Bioactive medications for the delivery of platelet derivatives to skin wounds

AU - Bonferoni, Maria Cristina

AU - Rossi, Silvia

AU - Sandri, Giuseppina

AU - Caramella, Carla

AU - Fante, Claudia Del

AU - Perotti, Cesare

AU - Miele, Dalila

AU - Vigani, Barbara

AU - Ferrari, Franca

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Chronic wounds are the result of alterations in the complex series of events of physiological wound healing. In particular, the prolonged inflammation results in increased protease activity, in the degradation of extracellular matrix (ECM) and of growth factors (GFs). The relevance of platelet GFs in maintaining and restoring the complex equilibrium of different moments in wound healing is well recognized. Moreover, the observed decrease of their levels in chronic wounds suggested a possible therapeutic role of the external application to the wounds. It has been also pointed out that tissue regeneration can be more efficiently obtained by the synergic use of different GFs. Platelet derivatives such as platelet-rich plasma (PRP) and platelet lysate (PL) are able to release GFs in a balanced pool. Their therapeutic use in regenerative medicine and wound healing has been therefore more and more frequently proposed in clinical trials and in the literature. The development of a suitable formulation able to control the GFs release rate, to protect the GFs, and to assure their prolonged contact with the wound site, is of paramount importance for the therapeutic success. The present review considers some formulation approaches for PRP and PL application to wounds.

AB - Chronic wounds are the result of alterations in the complex series of events of physiological wound healing. In particular, the prolonged inflammation results in increased protease activity, in the degradation of extracellular matrix (ECM) and of growth factors (GFs). The relevance of platelet GFs in maintaining and restoring the complex equilibrium of different moments in wound healing is well recognized. Moreover, the observed decrease of their levels in chronic wounds suggested a possible therapeutic role of the external application to the wounds. It has been also pointed out that tissue regeneration can be more efficiently obtained by the synergic use of different GFs. Platelet derivatives such as platelet-rich plasma (PRP) and platelet lysate (PL) are able to release GFs in a balanced pool. Their therapeutic use in regenerative medicine and wound healing has been therefore more and more frequently proposed in clinical trials and in the literature. The development of a suitable formulation able to control the GFs release rate, to protect the GFs, and to assure their prolonged contact with the wound site, is of paramount importance for the therapeutic success. The present review considers some formulation approaches for PRP and PL application to wounds.

KW - Drug delivery systems

KW - Extracellular matrix (ECM)

KW - Platelet lysate

KW - Platelet-rich plasma

KW - Skin regeneration

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=85065886776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065886776&partnerID=8YFLogxK

U2 - 10.2174/1381612825666190320154406

DO - 10.2174/1381612825666190320154406

M3 - Review article

C2 - 30894109

AN - SCOPUS:85065886776

VL - 16

SP - 472

EP - 483

JO - Current Drug Delivery

JF - Current Drug Delivery

SN - 1567-2018

IS - 5

ER -